Previous 10 | Next 10 |
RELIEF THERAPEUTICS Holding (RLFTF) and Acer Therapeutics (ACER) have entered into a Collaboration and License Agreement (“CLA”) for worldwide development and commercialization of ACER-001, a proprietary powder formulation of sodium phenylbutyrate ((NaPB)) designed to be both ta...
Relief to potentially pay Acer up to $36 million and royalties in exchange for net profit share and territory rights ACER-001 pre-NDA meeting with U.S. FDA scheduled in Q2 2021 GENEVA and NEWTON, Mass., March 22, 2021 (GLOBE NEWSWIRE) -- RELIEF THERAPEUTICS Holding AG (SIX: ...
Support.com (SPRT) +271% as Greenidge Generation Holdings to go public via merger with the company.Seneca Biopharma (SNCA) +30%.Cemtrex (CETX) +21%.Marker Therapeutics (MRKR) +19%.Acer Therapeutics (ACER) +19%.Kansas City Southern (KSU) +17% as Canadian Pacific to buy the company fo...
Gainers: SunLink Health Systems (SSY) +161%, Can-Fite BioPharma (CANF) +61%, Streamline Health Solutions (STRM) +56%, Anchiano Therapeutics (ANCN) +40%, Enzo Biochem (ENZ) +39%.Losers: Solid Biosciences (SLDB) -31%, Zynerba Pharmaceu...
CleanSpark (CLSK) -24% on raising $200M capital via equity offering.Takung Art (TKAT) -20%.Oriental Culture Holding (OCG) -24%.Sigma Labs (SGLB) -16%.Zynerba Pharmaceuticals (ZYNE) -14%.Solid Biosciences (SLDB) -15% after reports mid-stage data in Duchenne muscular dystrop...
Gainers: Check-Cap CHEK +138%, Rubius Therapeutics RUBY +81%, Intec Pharma NTEC +33%, GenMark Diagnostics GNMK +29%, Acer Therapeutics (ACER) +18%.Losers: Entera Bio (ENTX) -16%, NLS Pharmaceutics (NLSP) -15%, Seelos Therapeutic...
Intec Pharma Ltd (NTEC) +142% on announcing merger agreement with Decoy Biosystems.Check-Cap Ltd. (CHEK) +113% after receiving FDA IDE approval for pivotal study of C-Scan®.Acer Therapeutics (ACER) +67%.Shaw Communications (SJR) +55% as Rogers to acquire the company in C$2...
Penny Stocks To Watch For March 2021 If You Like The Biotech Sector As we approach the third week of March, penny stocks seem to be on a hot streak. This is a combination of the massive decline in covid cases and the $1.9 trillion stimulus package passing. Also, investors’ fear a...
Acer Therapeutics (ACER) has slipped 10% after filing a prospectus to sell ~4.05M shares for selling shareholders.ACER is not selling any securities under this prospectus and will not receive any of the proceeds from the sale of shares. For further details see: Acer Therapeuti...
Schrodinger SDGR -25% on Q4 earnings release.Purple Innovation PRPL -21% on Q4 earning release.Qutoutiao QTT -20% on Q4 earning release.Yext YEXT -19% on Q4 earning release.Vroom VRM -15% on Q4 earning release.KemPharm (KMPH) -13%.Salarius Pha...
News, Short Squeeze, Breakout and More Instantly...
Acer Therapeutics Inc. Company Name:
ACER Stock Symbol:
NASDAQ Market:
Acer Therapeutics Inc. Website:
AERWINS Technologies Inc. (AWIN) is expected to report for Q1 2024 Minera IRL Ltd ADR (MRLLY) is expected to report for quarter end 2023-09-30 SmileDirectClub, Inc. - Ordinary Shares - Class A (SDCCQ) is expected to report $-0.1 for Q3 2023 NextPlay Technologies Inc. (NXTP) is expecte...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Acer Therapeutics Inc. (ACER) is expected to report $-0.13 for Q3 2023